Ali Sadra

854 total citations
26 papers, 713 citations indexed

About

Ali Sadra is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ali Sadra has authored 26 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Ali Sadra's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Ali Sadra is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Ali Sadra collaborates with scholars based in South Korea, United States and Saudi Arabia. Ali Sadra's co-authors include Bo Dupont, Avery August, Hidesaburô Hanafusa, John B. Imboden, Sung‐Oh Huh, Tomáš Cinek, Kausik Bishayee, Md. Ataur Rahman, Philip D. King and Arnold Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Immunology and The Journal of Immunology.

In The Last Decade

Ali Sadra

25 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Sadra South Korea 13 366 326 116 98 51 26 713
Uschi Braun United States 7 254 0.7× 382 1.2× 114 1.0× 146 1.5× 32 0.6× 8 660
Charles Tindell United States 9 270 0.7× 411 1.3× 199 1.7× 188 1.9× 26 0.5× 10 748
Sylvie Rodrigues France 11 231 0.6× 436 1.3× 224 1.9× 98 1.0× 19 0.4× 11 801
Ganna Oliynyk Sweden 9 262 0.7× 418 1.3× 130 1.1× 212 2.2× 34 0.7× 13 768
J Horiguchi United States 11 417 1.1× 297 0.9× 139 1.2× 55 0.6× 21 0.4× 12 768
Simone Radtke Germany 14 259 0.7× 275 0.8× 402 3.5× 87 0.9× 39 0.8× 17 687
Katherine Ewings United Kingdom 7 167 0.5× 631 1.9× 181 1.6× 88 0.9× 63 1.2× 9 784
Z Zhao United States 11 470 1.3× 700 2.1× 112 1.0× 58 0.6× 19 0.4× 11 866
Thijs J. Hagenbeek Netherlands 8 354 1.0× 475 1.5× 182 1.6× 79 0.8× 23 0.5× 11 772
Adelyne Chan United Kingdom 12 161 0.4× 244 0.7× 98 0.8× 42 0.4× 30 0.6× 19 542

Countries citing papers authored by Ali Sadra

Since Specialization
Citations

This map shows the geographic impact of Ali Sadra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Sadra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Sadra more than expected).

Fields of papers citing papers by Ali Sadra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Sadra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Sadra. The network helps show where Ali Sadra may publish in the future.

Co-authorship network of co-authors of Ali Sadra

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Sadra. A scholar is included among the top collaborators of Ali Sadra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Sadra. Ali Sadra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Seung‐Hyuk, et al.. (2024). β-PIX-d, a Member of the ARHGEF7 Guanine Nucleotide Exchange Factor Family, Activates Rac1 and Induces Neuritogenesis in Primary Cortical Neurons. Experimental Neurobiology. 33(5). 215–224. 1 indexed citations
2.
Bishayee, Kausik, Uddin Md. Nazim, Vijay Kumar, et al.. (2022). Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma. Biomedicine & Pharmacotherapy. 150. 113032–113032. 12 indexed citations
3.
4.
Bishayee, Kausik, et al.. (2022). RNA binding protein HuD promotes autophagy and tumor stress survival by suppressing mTORC1 activity and augmenting ARL6IP1 levels. Journal of Experimental & Clinical Cancer Research. 41(1). 18–18. 12 indexed citations
5.
Lee, Chang‐Wook, et al.. (2022). Glutamine increases stability of TPH1 mRNA via p38 mitogen-activated kinase in mouse mastocytoma cells. Molecular Biology Reports. 50(1). 267–277.
6.
Kim, Nam‐Ho, Ali Sadra, Heeyoung Park, et al.. (2019). HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells.. PubMed. 42(2). 123–134. 2 indexed citations
7.
Bishayee, Kausik, et al.. (2019). Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas. Cellular Physiology and Biochemistry. 53(1). 258–280. 6 indexed citations
8.
Bishayee, Kausik, Vinay Dubey, Ali Sadra, & Sung‐Oh Huh. (2019). Targeting the difficult-to-drug CD71 and MYCN with gambogic acid and vorinostat an a class of neuroblastomas. IBRO Reports. 6. S426–S426. 1 indexed citations
9.
10.
Sadra, Ali, et al.. (2017). Gastroprotective and gastric motility benefits of AD-lico/Healthy Gut™ Glycyrrhiza inflata extract. Animal Cells and Systems. 21(4). 255–262. 5 indexed citations
11.
Rahman, Md. Ataur, et al.. (2016). 18α-Glycyrrhetinic acid lethality for neuroblastoma cells via de-regulating the Beclin-1/Bcl-2 complex and inducing apoptosis. Biochemical Pharmacology. 117. 97–112. 27 indexed citations
12.
Rahman, Md. Ataur, Kausik Bishayee, Ali Sadra, & Sung‐Oh Huh. (2016). Oxyresveratrol activates parallel apoptotic and autophagic cell death pathways in neuroblastoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 23–36. 53 indexed citations
13.
Zhang, Hongbing, Kevin P. Baker, Ali Sadra, et al.. (2007). FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis. Molecular Cancer Therapeutics. 6. 11 indexed citations
14.
Andres, Pietro G., Ajay Nirula, Larry Kane, et al.. (2004). Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nature Immunology. 5(4). 435–442. 55 indexed citations
15.
Sadra, Ali, Tomáš Cinek, & John B. Imboden. (2000). Multiple Probing of an Immunoblot Membrane Using a Non-Block Technique: Advantages in Speed and Sensitivity. Analytical Biochemistry. 278(2). 235–237. 13 indexed citations
16.
Cinek, Tomáš, Ali Sadra, & John B. Imboden. (2000). Cutting Edge: Tyrosine-Independent Transmission of Inhibitory Signals by CTLA-4. The Journal of Immunology. 164(1). 5–8. 45 indexed citations
17.
King, Philip D., Ali Sadra, Joyce Teng, et al.. (1997). Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. The Journal of Immunology. 158(2). 580–590. 62 indexed citations
18.
August, Avery, Ali Sadra, Bo Dupont, & Hidesaburô Hanafusa. (1997). Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proceedings of the National Academy of Sciences. 94(21). 11227–11232. 158 indexed citations
19.
King, Philip D., Ali Sadra, Arnold Han, et al.. (1996). CD2 singnaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. International Immunology. 8(11). 1707–1714. 34 indexed citations
20.
Teng, Joyce, Philip D. King, Ali Sadra, et al.. (1996). Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28‐induced T cell IL‐2 secretion. Tissue Antigens. 48(4). 255–264. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uschi Braun Breakdown of academic impact, for papers by Charles Tindell Breakdown of academic impact, for papers by Sylvie Rodrigues Breakdown of academic impact, for papers by Ganna Oliynyk Breakdown of academic impact, for papers by J Horiguchi Breakdown of academic impact, for papers by Simone Radtke Breakdown of academic impact, for papers by Katherine Ewings Breakdown of academic impact, for papers by Z Zhao Breakdown of academic impact, for papers by Thijs J. Hagenbeek Breakdown of academic impact, for papers by Adelyne Chan
Rankless by CCL
2026